Table 1: Baseline description of the sample.

Supplementation groupPlacebo group

Randomized patients6561
Male/female19/4620/41
Age (yr) (mean ± SD)45.85 ± 16.6148.05 ± 17.02
Type of functional dyspepsia (FD)
 Ulcer-like FD56
 Dysmotility-like FD3933
 Unspecified FD2122

Significant differences are absent when the intervention and the placebo groups are compared.